This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Web of Science (7) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kurita, A. Articles by Satomura, K. Search for Related Content PubMed PubMed Citation Articles by Kurita, A. Articles by Satomura, K. Social Bookmarking                         What's this?

Significance of Plasma Nitric Oxide/Endothelial-1 Ratio for Prediction of Coronary Artery Disease

Sanai Hospital, Tokyo, Japan, a-kurita{at}msi.biglobe.ne.jp

Takemi Matsui, PhD

Department of Biomedical Engineering and Internal Medicine, National Defense Medical College, Saitma

Toshiaki Ishizuka, MD

Department of Biomedical Engineering and Internal Medicine, National Defense Medical College, Saitma

Bonpei Takase, MD

Department of Biomedical Engineering and Internal Medicine, National Defense Medical College, Saitma

Kimio Satomura, MD

Department of Biomedical Engineering and Internal Medicine, National Defense Medical College, Saitma

Vascular tone is regulated by vasodilators and vasoconstrictors. Endothelin-1 (ET-1) is the predominant vasoconstrictor peptide that constricts vascular smooth muscle, whereas nitric oxide (NO) is the primary vasodilator peptide that relaxes vascular smooth muscle. In this study, the authors examined whether NO/ET-1 ratio is a useful marker for detecting coronary artery disease (CAD), by comparison with evaluation based on vascular endothelial (VE) function. They measured plasma NOX and ET-1 by using ENO-200 and radioimmunoassay, in 38 subjects with normal (NL) coronary arteries (NL group; mean age, 60 ±12 years) and 25 subjects with CAD (CAD group; mean age, 69 ±6 years). VE function (randomized endothelium-dependent [D] and endothelium-independent [I] VE function) was assessed by measuring brachial artery (BA) diameter by using high-resolution ultrasound (7.5 MHz). Soon after these procedures, symptom-limited exercise testing was performed. There were no statistically significant differences in serum lipid concentrations or VED function between the groups. However, the CAD group had a significantly lower NO/ET-1 ratio (1.2 ±1.1 vs 2.7 ±2.2, p<0.01) and BA diameter after sublingual nitroglycerin (VEID function: 6 ±7% vs 10 ±4%, p<0.05). As expected, the ST segment and treadmill exercise duration were significantly lower in the CAD group. Sensitivity and specificity for detecting CAD by plasma NO/ET-1 ratio (2.0) were 90% and 85%, respectively; sensitivity and specificity for detecting CAD by ST depression (1 mm) were 80% and 78%, respectively. The present results suggest that plasma NO/ET-1 ratio is a useful biological marker for predicting CAD.

Angiology, Vol. 56, No. 3, 259-264 (2005)
DOI: 10.1177/000331970505600304


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?